[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Relief Therapeutics Hldg (RLFTF)

Relief Therapeutics Hldg (RLFTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2144 +14.27%
on 07/06/26
0.3754 -34.74%
on 06/11/26
-0.1472 (-37.53%)
since 06/10/26
3-Month
0.2144 +14.27%
on 07/06/26
0.5856 -58.16%
on 05/21/26
-0.1349 (-35.51%)
since 04/10/26
52-Week
0.2144 +14.27%
on 07/06/26
4.8800 -94.98%
on 10/08/25
-2.6050 (-91.40%)
since 07/10/25

Most Recent Stories

More News
Relief Therapeutics and NeuroX Merge to Form AI-Driven Health Tech Leader

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. RELIEF THERAPEUTICS...

RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update

GENEVA, SWITZERLAND / ACCESS Newswire / April 10, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment...

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion

GENEVA, SWITZERLAND / ACCESS Newswire / March 6, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative...

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011

Patent Secures Protection for RLF-TD011 in Epidermolysis Bullosa Wound Treatment

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US

Sale of GOLIKE® Rights Outside the U.S. to NutrisensRelief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Provides Update on Potential Transaction with Renexxion

GENEVA, SWITZERLAND / ACCESSWIRE / December 27, 2024 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative...

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial

Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU Patients

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations

Company to Maintain SIX Swiss Exchange Listing, U.S. ADR Program, and U.S. OTCQB Quotation

RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2450 (-3.54%)
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

/CNW/ -- RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying,...

RLFTF : 0.2450 (-3.54%)
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

/PRNewswire/ -- RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying,...

RLFTF : 0.2450 (-3.54%)

Key Turning Points

3rd Resistance Point 0.2637
2nd Resistance Point 0.2599
1st Resistance Point 0.2525
Last Price 0.2450
1st Support Level 0.2413
2nd Support Level 0.2375
3rd Support Level 0.2301

See More

52-Week High 4.8800
Fibonacci 61.8% 3.0977
Fibonacci 50% 2.5472
Fibonacci 38.2% 1.9967
Last Price 0.2450
52-Week Low 0.2144

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.